Three-hour mandatory vaccination training fails to consider GP expertise The RACGP is strongly advocating for any education and training to address GPs’ needs and avoid taking up critical time.
New considerations for GPs ahead of vaccine rollout Recent studies suggest some coronavirus variants may reduce vaccine efficacy rates. newsGP explores what this could mean for GPs.
‘The beginning of the end of this pandemic’ The Oxford University/AstraZeneca coronavirus vaccine has been approved for use in Australia, while the first doses of Pfizer/BioNTech’s candidate will start being administered next week.
What should GPs do to get ready for the vaccine push? Get your technology sorted as soon as possible, according to a GP technology expert.
‘Professional attendance’ a sticking point in COVID vaccine rollout More than 5000 general practices have put their hand up to take part in the nationwide vaccination program, but questions over MBS rebate requirements could stall momentum.
Vaccine’s reduced efficacy against COVID variant ‘worrying’ South Africa has paused its rollout of the Oxford University/AstraZeneca coronavirus vaccine. What does this mean for Australia?
ACCHOs face challenges of vaccine rollout to remote communities As Australia’s COVID vaccination campaign inches closer, Aboriginal health services prepare for a mammoth effort.
Pfizer/BioNTech COVID vaccine approved for use in older Australians The TGA has said there is ‘no specific risk’ associated with vaccinating older people, following reports of deaths in Norway.
Prime Minister reveals further $1.9 billion to support vaccine rollout General practice is expected to receive a substantial amount of the new allocation, but details remain limited.
Novavax confirms efficacy against emerging coronavirus variants New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.